Phase 2 Trial of Single-Agent Cobimetinib for Adults with Histiocytic Neoplasms

被引：2
|
作者：
Diamond, Eli L. [1 ]
Durham, Benjamin [2 ]
Dogan, Ahmet [3 ]
Yabe, Mariko [4 ]
Petrova-Drus, Kseniya [3 ]
Rampal, Raajit K. [5 ]
Ulaner, Gary [6 ]
Lacouture, Mario [7 ]
Rotemberg, Veronica [7 ]
Covey, Anne [2 ]
Brody, Lynn [8 ]
Abdel-Wahab, Omar [9 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, Dept Neurol, New York, NY USA
[2] Mem Sloan Kettering Canc Ctr, New York, NY USA
[3] Mem Sloan Kettering Canc Ctr, Dept Pathol & Lab Med, Hematopathol Serv, New York, NY USA
[4] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY USA
[5] Mem Sloan Kettering Canc Ctr, Dept Med, Leukemia Serv, New York, NY USA
[6] Hoag Family Canc Inst, Newport Beach, CA USA
[7] Mem Sloan Kettering Canc Ctr, Dept Med, Dermatol Serv, New York, NY USA
[8] MSKCC, New York, NY USA
[9] Mem Sloan Kettering Canc Ctr, Mol Pharmacol Program, New York, NY USA
来源：
BLOOD | 2023年 / 142卷
关键词：
D O I：
10.1182/blood-2023-187508
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：4
相关论文
共 50 条
  • [31] Phase II trial of single-agent weekly docetaxel in hormone-refractory, symptomatic, metastatic carcinoma of the prostate
    Berry, W
    Dakhil, S
    Gregurich, MA
    Asmar, L
    SEMINARS IN ONCOLOGY, 2001, 28 (04) : 8 - 15
  • [32] Phase II Trial of Single-Agent Bevacizumab Followed by Bevacizumab Plus Irinotecan at Tumor Progression in Recurrent Glioblastoma
    Kreisl, Teri N.
    Kim, Lyndon
    Moore, Kraig
    Duic, Paul
    Royce, Cheryl
    Stroud, Irene
    Garren, Nancy
    Mackey, Megan
    Butman, John A.
    Camphausen, Kevin
    Park, John
    Albert, Paul S.
    Fine, Howard A.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (05) : 740 - 745
  • [33] Avelumab in Patients With Gestational Trophoblastic Tumors With Resistance to Single-Agent Chemotherapy: Cohort A of the TROPHIMMUN Phase II Trial
    You, Benoit
    Bolze, Pierre-Adrien
    Lotz, Jean-Pierre
    Massardier, Jerome
    Gladieff, Laurence
    Joly, Florence
    Hajri, Touria
    Maucort-Boulch, Delphine
    Bin, Sylvie
    Rousset, Pascal
    Devouassoux-Shisheboran, Mojgan
    Roux, Adeline
    Alves-Ferreira, Marine
    Grazziotin-Soares, Daniele
    Langlois-Jacques, Carole
    Mercier, Catherine
    Villeneuve, Laurent
    Freyer, Gilles
    Golfier, Francois
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (27) : 3129 - +
  • [34] A phase II dose-ranging trial of single-agent pamidronate for relapsed/refractory multiple myeloma.
    Berenson, J
    Webb, I
    Henick, K
    Vescio, R
    Swift, R
    Anderson, K
    Seaman, J
    BLOOD, 1998, 92 (10) : 107A - 107A
  • [35] Pooled safety analysis of single-agent lurbinectedin versus topotecan (Results from a randomized phase III trial CORAIL and a phase II basket trial).
    Leary, Alexandra
    Gaillard, Stephanie
    Vergote, Ignace
    Trigo, Jose
    Kahatt, Carmen Maria
    Nieto, Antonio
    Fernandez, Cristian Marcelo
    Cullell-Young, Martin
    Zeaiter, Ali Hassan
    Subbiah, Vivek
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [36] SINGLE-AGENT CARBOPLATINUM FOR ADVANCED SEMINOMA - A PHASE-II STUDY
    SCHMOLL, HJ
    HARSTRICK, A
    BOKEMEYER, C
    DIECKMANN, KP
    CLEMM, C
    BERDEL, WE
    SOUCHON, R
    SCHOBER, C
    WILKE, H
    POLIWODA, H
    CANCER, 1993, 72 (01) : 237 - 243
  • [37] A PROSPECTIVE RANDOMIZED TRIAL OF SINGLE-AGENT VERSUS COMBINATION CHEMOTHERAPY IN MENINGEAL CARCINOMATOSIS
    HITCHINS, RN
    BELL, DR
    WOODS, RL
    LEVI, JA
    JOURNAL OF CLINICAL ONCOLOGY, 1987, 5 (10) : 1655 - 1662
  • [38] Phase 2 Trial of Single-agent Everolimus in Chemotherapy-naive Patients with Castration-resistant Prostate Cancer (SAKK 08/08)
    Templeton, Arnoud J.
    Dutoit, Valerie
    Cathomas, Richard
    Rothermundt, Christian
    Baertschi, Daniela
    Droege, Cornelia
    Gautschi, Oliver
    Borner, Markus
    Fechter, Eva
    Stenner, Frank
    Winterhalder, Ralph
    Mueller, Beat
    Schiess, Ralph
    Wild, Peter J.
    Rueschoff, Jan H.
    Thalmann, George
    Dietrich, Pierre-Yves
    Aebersold, Ruedi
    Klingbiel, Dirk
    Gillessen, Silke
    EUROPEAN UROLOGY, 2013, 64 (01) : 150 - 158
  • [39] A Phase 2 Trial of Single-Agent Bevacizumab Given in an Every-3-Week Schedule for Patients With Recurrent High-Grade Gliomas
    Raizer, Jeffrey J.
    Grimm, Sean
    Chamberlain, Marc C.
    Nicholas, M. Kelly
    Chandler, James P.
    Muro, Kenji
    Dubner, Steven
    Rademaker, Alfred W.
    Renfrow, Jaclyn
    Bredel, Markus
    CANCER, 2010, 116 (22) : 5297 - 5305
  • [40] Single-Agent Ibrutinib for Rituximab-Refractory Waldenstrom Macroglobulinemia: Final Analysis of the Substudy of the Phase III Innovate™ Trial
    Trotman, Judith
    Buske, Christian
    Tedeschi, Alessandra
    Matous, Jeffrey V.
    MacDonald, David
    Tam, Constantine S.
    Tournilhac, Olivier
    Ma, Shuo
    Treon, Steven P.
    Oriol, Albert
    Ping, Jerry
    Briso, Eva M.
    Arango-Hisijara, Israel
    Dimopoulos, Meletios A.
    CLINICAL CANCER RESEARCH, 2021, 27 (21) : 5793 - 5800
12345